A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.
This study has been completed.
Study NCT00677001
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on April 24, 2008.
Last Updated on April 26, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
